A comprehensive review of new small molecule drugs approved by the FDA in 2022: Advance and prospect.

MLA

Bai, Yi-Ru, et al. “A Comprehensive Review of New Small Molecule Drugs Approved by the FDA in 2022: Advance and Prospect.” European Journal of Medicinal Chemistry, vol. 277, Nov. 2024, p. 116759. EBSCOhost, https://doi.org/10.1016/j.ejmech.2024.116759.

APA

Bai, Y.-R., Yang, X., Chen, K.-T., Cuan, X.-D., Zhang, Y.-D., Zhou, L., Yang, L., Liu, H.-M., & Yuan, S. (2024). A comprehensive review of new small molecule drugs approved by the FDA in 2022: Advance and prospect. European Journal of Medicinal Chemistry, 277, 116759. https://doi.org/10.1016/j.ejmech.2024.116759

Chicago

Bai, Yi-Ru, Xin Yang, Ke-Tong Chen, Xiao-Dan Cuan, Yao-Dong Zhang, Li Zhou, Li Yang, Hong-Min Liu, and Shuo Yuan. 2024. “A Comprehensive Review of New Small Molecule Drugs Approved by the FDA in 2022: Advance and Prospect.” European Journal of Medicinal Chemistry 277 (November): 116759. doi:10.1016/j.ejmech.2024.116759.